Hot Products
| Catalog No. | Information |
| CFN89426 | 11-Anhydro-16-oxoalisol A Reference standards. |
| CFN98345 | 11beta-Hydroxycedrelone 11β-Hydroxycedrelone has cytotoxic activity, it exhibits moderate inhibitory activity against HL-60 cell line with the IC50 values of 8.9 uM. |
| CFN90052 | 11Beta-hydroxyprogesterone The progesterone derivatives 11 alpha- and 11 beta-hydroxyprogesterone are potent inhibitors of 11 beta-hydroxysteroid dehydrogenase (isoforms 1 and 2) in vitro and can confer mineralocorticoid activity on corticosterone in the rat in vivo. 11beta-Hydroxyprogesterone acts as a mineralocorticoid agonist in stimulating Na+ absorption in mammalian principal cortical collecting duct cells. |
| CFN92401 | 11-Deoxyalisol B Reference standards. |
| CFN92125 | 11-Hydroxycanthin-6-one 11-Hydroxy-canthin-6-one has antineoplastic activity. |
| CFN97887 | 11-Hydroxygelsenicine Standard reference |
| CFN97998 | 11-Hydroxyhumantenine Standard reference |
| CFN90366 | 11-Hydroxy-sugiol Reference standards. |
| CFN98205 | 11-Hydroxytabersonine 11-Hydroxytabersonine has antitumor activety. |
| CFN90152 | 11-Keto-beta-boswellic acid 11-Keto-beta-boswellic acid, a novel Nrf2 activator, and a selective 5-lipoxygenase (5-LOX) inhibitor; it exerts dose dependent cardioprotective effect manifested by dose-dependent reduction in serum lactate dehydrogenase; and it can increase the Nrf2 and HO-1 expression, which provides protection against oxygen and glucose deprivation (OGD)-induced oxidative insult. 11-Keto-beta-boswellic acid possesses significant anti-inflammatory, and anti-tumoral activities. |
